相关实验视频
Updated: Jul 27, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
克罗恩病中的多种病:来自内部的新见解
Chenlu Mu1, Qianjing Zhao1, Qing Zhao1
1Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China.
Computational and structural biotechnology journal
|June 5, 2023
概括
多omics分析提供了一种全面的方法来理解克罗恩病.
科学领域:
- 胃肠道学和免疫学
- 基因组学,表观基因组学,微生物组学,代谢学和蛋白质组学.
背景情况:
- 克罗恩病 (CD) 是一种炎症性肠病 (IBD),表现出复杂的症状,尽管全球发病率不断上升,但缺乏确定的治疗方法.
- 目前对疾病病原学的理解受限于单一的奥米克技术无法整体地解决疾病异质性的问题.
研究的目的:
- 审查和综合与克罗恩病研究相关的独特omics特征和应用.
- 讨论当前多学科方法在探索CD方面的进展和局限性.
- 突出综合体学的潜力,开发针对性,个性化的CD治疗方法.
主要方法:
- 审查高通量测序技术和综合的奥米克分析,包括基因组学,表观基因组学,微生物组,代谢学和蛋白质组学.
- 分析不同omics数据类型如何有助于理解CD病变发生,生物标志物和宿主微生物相互作用.
- 重点是整合多个omics数据集,以全面查看CD.
主要成果:
- 主体基因组学和表观基因组学揭示了CD易感性的遗传因素.
- 微生物组和代谢学研究阐明了CD患者的宿主-微生物相互作用.
- 蛋白质组学在识别CD生物标志物方面表现有前途.
结论:
- 单一的omics方法不足以完全将CD机制与病理异质性联系起来.
- 多omics分析,通过整合不同的数据,为深入的CD探索提供了一个强大的工具.
- 这种综合方法为推进克罗恩病的有针对性和个性化治疗策略提供了新的希望.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
303
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
303
Genomics
36.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
204
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
204
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
364
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
364
Inflammatory Bowel Disease I: Ulcerative Colitis
227
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
227
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177

